×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
返回 Agenda
Session 9: AI
Session Chair(s)
Keri Monda, PhD, MS
Executive Director, Center for Observational Research
Amgen, United States
Session 9: AI
Speaker(s)
Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes, MOSAIC-NLP Part II
Elise Berliner, PhD
Oracle Life Sciences, United States
Global Senior Principal for Real World Evidence Strategy
Unleashing RWD and RWE: Transforming Clinical Study Design with Generative AI
Susant Mallick, MBA
Cloudhub BV, Netherlands
Founder and CEO, Life Sciences Practice Leader
Leveraging RWD to Enable Predictive Treatment Effect Modelling in Personalized Medicine
Flavio Dormont, PhD, MBA, MS
Sanofi, United States
Therapeutic Area Head, Clinical Development RWE